Fdc Sales Mis < 2K 2024 >

Palpitations. The steroid component had a known but rare cardiac risk. In clinical trials, it occurred in 0.3% of patients. But if even one patient reported it to a senior doctor like Iyengar, she would blacklist the FDC forever. The MIS, however, would not capture why she stopped. It would only show a line descending. Numbers without stories were dangerous.

Arjun did something unorthodox. He opened the raw SQL database behind the MIS—the tables the dashboards were built on. He wrote a query to join prescriber data with patient redemption data with stockist return data . Then he looked at the time stamps.

Someone was entering fake prescriptions into the system to game the CRM. Fdc Sales Mis

“Arjun bhai, your Nebuflam-D is moving slow because the retailers are scared. Two months ago, the state drug controller banned another FDC—same steroid, different company. The wholesalers are still stuck with thirty lakhs of expired stock. So now, every time a retailer sees ‘low-dose steroid’ on a combo, they think: next ban . They order just one strip at a time. And the patient? If the doctor writes a combo, the patient asks the chemist, ‘Can I take just the expectorant alone?’ Then they buy half a course.”

He pulled up the prescription trend for Dr. Meera Iyengar, a pulmonologist in the city’s top lung hospital. Her prescription numbers for Nebuflam-D had gone from zero to forty in the first week—after his star rep had visited her thrice—and then dropped to two in the third week. But the MIS showed zero patient redemptions from her prescriptions. That meant either patients weren’t buying it, or the prescriptions were never written. Palpitations

A pattern emerged.

Or so they believed.

Arjun closed the drawer. He looked at the MIS dashboard on her screen—the same one his boss saw every morning. It glowed with confidence: green arrows, rising trends, forecast accuracy of 94%. None of it was real.

Arjun had been a regional sales manager for eleven years. He had seen doctors change prescription habits, drug reps morph into digital avatars, and CRM tools evolve from paper diaries to AI-driven dashboards. But nothing—nothing—had prepared him for the silence that came after the launch of the new FDC. But if even one patient reported it to

Outside, the city was asleep. But somewhere, a patient with chronic bronchitis was breathing shallowly, having bought only half a course of the expectorant, leaving the steroid untouched—because a chemist had whispered, “Don’t take this combo, beta. Too risky.”